(Medical Xpress)—The average skin cancer risk from sunbeds is more than double that of spending the same length of time in the Mediterranean midday summer sun – according to new research from the University of Dundee ...
Jan 17, 2013
0
0
(Medical Xpress)—Worried about all the time you spent in the sun during your teen years? There's good reason, says Dr. Jane M. Grant-Kels, chair of the Department of Dermatology at the University of Connecticut Health Center.
Jan 7, 2013
0
0
After recently announcing success in eliminating melanoma metastasis in laboratory experiments, scientists at Virginia Commonwealth University Massey Cancer Center have made another important discovery in understanding the ...
Jan 3, 2013
0
0
(Medical Xpress)—A University of Colorado Cancer Center study in this month's edition of the Journal of Investigative Dermatology describes a new target and potential treatment for melanoma, the most dangerous form of skin ...
Dec 20, 2012
0
0
(HealthDay)—The cost of lost productivity among U.S. workers with cancer is equal to 20 percent of the nation's health care spending, according to a new study.
Dec 17, 2012
0
0
With the X-ray vision of DESY's light source DORIS, a research team from Hamburg and Iceland has uncovered the molecular structure of a master regulator central to the most deadly form of skin cancer, melanoma. The results, ...
Dec 1, 2012
0
0
Taxpayers will be spending over $700m annually to treat Australia's most common skin cancers by the year 2015, with over-65s making up the bulk of patients, a new study has found.
Nov 19, 2012
0
0
In laboratory experiments, scientists have eliminated metastasis, the spread of cancer from the original tumor to other parts of the body, in melanoma by inhibiting a protein known as melanoma differentiation associated gene-9 ...
Nov 14, 2012
0
0
(Medical Xpress)—Results of a University of Arizona Cancer Center's scientist-led clinical trial show that a drug already approved for breast and lung cancer improved progression-free survival in patients with metastatic ...
Nov 14, 2012
0
0
The humanized antibody ipilimumab (trade name Yervoy) has been approved since August 2011 for the treatment of adult patients with advanced melanoma (black skin cancer) who have already been treated. The term "advanced" means ...
Nov 9, 2012
0
0
